Corbyn Investment Management’s iShares US Broker-Dealers & Securities Exchanges ETF IAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,721
Closed -$221K 68
2024
Q3
$221K Hold
1,721
0.08% 64
2024
Q2
$201K Sell
1,721
-424
-20% -$48.9K 0.08% 65
2024
Q1
$249K Sell
2,145
-28
-1% -$3.04K 0.11% 59
2023
Q4
$236K Sell
2,173
-41
-2% -$3.92K 0.11% 56
2023
Q3
$202K Hold
2,214
0.1% 57
2023
Q2
$201K Sell
2,214
-47
-2% -$4.21K 0.1% 61
2023
Q1
$207K Buy
2,261
+18
+0.8% +$1.77K 0.08% 63
2022
Q4
$216K Buy
+2,243
New +$215K 0.09% 60
2022
Q2
Sell
-2,436
Closed -$243K 85
2022
Q1
$243K Sell
2,436
-307
-11% -$32.4K 0.08% 69
2021
Q4
$302K Buy
2,743
+308
+13% +$34.2K 0.09% 65
2021
Q3
$254K Hold
2,435
0.08% 67
2021
Q2
$249K Buy
+2,435
New +$240K 0.09% 60

Other funds holding IAI

Corbyn Investment Management's IAI Position: Q4 2024 in Review

Corbyn Investment Management sold out of iShares US Broker-Dealers & Securities Exchanges ETF (IAI) in Q4 2024, closing a stake of 1,721 shares — an estimated $221K sold.

Corbyn Investment Management first reported a position in IAI in Q2 2021 and held it in 12 quarters. The position peaked at $302K in Q4 2021. 182 funds tracked by Wall St. Rank hold IAI as of Q4 2024.

  • Corbyn Investment Management reported no remaining iShares US Broker-Dealers & Securities Exchanges ETF position as of Q4 2024 after selling out during the quarter.
  • Corbyn Investment Management sold 1,721 iShares US Broker-Dealers & Securities Exchanges ETF shares in Q4 2024, an estimated $221K.
  • Corbyn Investment Management first reported a position in iShares US Broker-Dealers & Securities Exchanges ETF in Q2 2021 and held it in 12 quarters.
  • Corbyn Investment Management's iShares US Broker-Dealers & Securities Exchanges ETF position peaked at $302K in Q4 2021.
  • 182 funds tracked by Wall St. Rank held iShares US Broker-Dealers & Securities Exchanges ETF as of Q4 2024.

Based on Corbyn Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.